2021
DOI: 10.1371/journal.pone.0254101
|View full text |Cite
|
Sign up to set email alerts
|

Next-generation sequencing of BRCA1 and BRCA2 genes in Moroccan prostate cancer patients with positive family history

Abstract: Prostate cancer is the most common male cancer in Morocco. Although sporadic forms account for a large proportion of patients, familial forms of prostate cancer are observed in 20% of cases and about 5% are due to hereditary transmission. Indeed, germline mutations in BRCA1/2 genes have been associated with prostate cancer risk. However, the spectrum of these mutations was not investigated in Moroccan Prostate cancer patients. Thereby, the aim of this study was to characterize and to estimate the prevalence of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 75 publications
1
3
0
Order By: Relevance
“…This intriguing ethnic diversity indicates Egypt's unique genetic composition, situated as a transcontinental nation between the northeastern corner of Africa and the southwestern corner of Asia. Notably, previous research corroborates these findings, as the identified BRCA1 (c.4900A > G, c.2612C > T, c.3548A > G, 0.3113A > G) and BRCA2 (c.7397 T > C, c.1114A > C) clusters were observed in an earlier Egyptian study [ 67 ] as well as within Arab African populations like Algerian [ 68 ], Bahrainian [ 69 ], Moroccan [ 70 ] and Tunisian [ 71 ] groups, alongside Asian populations encompassing Chinese [ 72 ], Korean [ 73 ], Iranian [ 74 ] and Indian [ 75 ] cohorts, and even in American and European populations such as Brazilian [ 76 ], and Italian [ 77 ] ones, respectively. This reinforces the intricate interplay of various ethnic backgrounds shaping the genetic landscape of Egypt.…”
Section: Discussionsupporting
confidence: 70%
“…This intriguing ethnic diversity indicates Egypt's unique genetic composition, situated as a transcontinental nation between the northeastern corner of Africa and the southwestern corner of Asia. Notably, previous research corroborates these findings, as the identified BRCA1 (c.4900A > G, c.2612C > T, c.3548A > G, 0.3113A > G) and BRCA2 (c.7397 T > C, c.1114A > C) clusters were observed in an earlier Egyptian study [ 67 ] as well as within Arab African populations like Algerian [ 68 ], Bahrainian [ 69 ], Moroccan [ 70 ] and Tunisian [ 71 ] groups, alongside Asian populations encompassing Chinese [ 72 ], Korean [ 73 ], Iranian [ 74 ] and Indian [ 75 ] cohorts, and even in American and European populations such as Brazilian [ 76 ], and Italian [ 77 ] ones, respectively. This reinforces the intricate interplay of various ethnic backgrounds shaping the genetic landscape of Egypt.…”
Section: Discussionsupporting
confidence: 70%
“…The second pathogenic variant (c.4986 + 6 T > C) in BRCA1 carried by seven of our BC patients has also been detected in multiple African patients with an early-onset of BC [ 34 , 35 ]. This splicing site variant is located in highly conserved human genome region and seems to activate a cryptic splice donor site which alters the reading frame resulting in absent or truncated protein [ 36 , 37 ]. It was proposed by ClinVar as pathogenic germline allele by numerous submitters [ 35 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…The DNA damage repair (DDR) process uses non-conservative and potentially mutagenic methods when these BRCA1 and/or BRCA2 genes are absent. There is evidence that this genomic instability contributes to the cancer risk associated with harmful BRCA gene mutations ( Salmi et al, 2021 ). BRCA1 and BRCA2 pathogenic mutation carriers have a relative risk of PCa that is enhanced by 1.8–3.8 and 2.5 to 8.6 times, respectively, by the time they are 65 years old ( Thompson et al, 2003 ; Agalliu et al, 2007 ; Leongamornlert et al, 2012 ).…”
Section: Challenges and Controversies In The Management Of Prostate C...mentioning
confidence: 99%